EXMceuticals Inc. (9OM1.F)

0.1230 0.0000 (0.00%) At close: 09:03AM CET

EXMceuticals Inc.

421 7th Avenue SW
30th Floor
Calgary, AB T2P 4K9
Canada
587 390 8541
https://exmceuticals.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jonathan William Summers	Exec. Chairman & CEO	N/A	N/A	1971
Mr. Michael Winslow Kinley C.A., CPA	CFO & Director	N/A	N/A	1951
Mr. Paulo Martins	CEO & Country Director of its operations in Portugal	N/A	N/A	N/A
Ms. Julie Lemieux	VP of Canadian Operations & Corp. Sec.	N/A	N/A	N/A

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

EXMceuticals Inc. engages in the production of cannabinoid formulations. The company primarily focuses around the matching of natural bioactive ingredients extracted from the cannabis plant with the needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. It focuses on the production of CBD, a non-psychoactive cannabinoid that has been proven effective against acne, anxiety, depression, epilepsy, and degenerative diseases, such as Parkinson's; and THC, a psychoactive cannabinoid ingredient that has been proven effective in the fields of pain management, appetite control, anxiety, and managing side effects of chemotherapy. The company was incorporated in 2008 and is headquartered in Quebec, Canada.

Corporate Governance

EXMceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.